February 5, 2026

Affinia receives FDA approval for Phase I/II trial for dilated cardiomyopathy

​Affinia Therapeutics has received approval from the US FDA for an IND application to initiate the UPBEAT Phase I/II trial...

February 5, 2026

PrimeGen US and DT Cloud Star sign $1.5bn merger agreement 

​PrimeGen US and DT Cloud Star Acquisition have entered a definitive merger agreement at an implied equity value of around...

February 4, 2026

Endospan reports one-year TRIOMPHE study results for NEXUS system

​Endospan has announced positive one-year results from the TRIOMPHE study evaluating its NEXUS aortic arch stent-graft system.The post Endospan reports...

February 4, 2026

Biosion doses first patient in Phase Ia/Ib BSI-082 trial for solid tumours

​Biosion has dosed the first patient in an investigator-initiated Phase Ia/Ib trial of BSI-082, aimed at treating advanced solid tumours.The...

February 4, 2026

CEPI and Samsung Biologics partner to boost global vaccine preparedness

​CEPI and Samsung Biologics have partnered in an outbreak-ready vaccine manufacturing partnership to enhance the preparedness of global vaccine production...

February 3, 2026

Medtronic achieves three milestones for MiniMed 780G system in US

​Medtronic has reported three milestones in the US, expanding access to its MiniMed 780G insulin delivery system for individuals with...

February 3, 2026

Arcutis reports positive topline data in Zoryve trial for infant AD

​Arcutis has reported positive topline data from the INTEGUMENT-INFANT Phase II trialassessing Zoryve cream 0.05% in infants aged three months...

February 3, 2026

Aquestive receives FDA CRL for Anaphylm allergic reaction treatment

​Aquestive has received a CRL from the FDA regarding its NDA for Anaphylm, which aims to treat type I allergic...

February 2, 2026

ALX Oncology announces Phase Ib/II trial results for breast cancer

​ALX Oncology has announced new data from a Phase Ib/II clinical trial of its CD47-inhibitor, evorpacept, combined with Jazz Pharmaceuticals’...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.